Comparative analysis of screening results from various ELISA formats used for detection of anti-erythropoietin antibodies in Korean patients

Biomolecules and Therapeutics

Volumn 18, Issue 2, 2010, Pages 184-190

  Ha, Sung Kyu ^a   Yang, Seung Ju ^b   Shin, Sug Kyun ^c   Jo, Young Il ^d   Baek, Kyung Min ^e   Hong, Seung Hwa ^e   Pack, Seung Pil ^f   Kim, Sung Jo ^g   Heo, Tae Hwe ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Konyang University   (South Korea)

^c National Health Insurance Corporation   (South Korea)

^d Konkuk University School of Medicine   (South Korea)

^e Korea Food and Drug Administration   (South Korea)

^f Korea University   (South Korea)

^g Hoseo University   (South Korea)

Author keywords

Bridging ELISA; Erythropoietin; Immunogenicity; Pure red cell aplasia

Indexed keywords

ERYTHROPOIETIN ANTIBODY; STREPTAVIDIN;

ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; BLOOD SAMPLING; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; HUMAN; IMMUNOGENICITY; INTERMETHOD COMPARISON; KOREA; PROTEIN INTERACTION; SCREENING TEST; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING;

EID: 77953100891     PISSN: 19769148     EISSN: None     Source Type: Journal    
DOI: 10.4062/biomolther.2010.18.2.184     Document Type: Article

References (18)

1. Bennett, C. L., Luminari, S., Nissenson, A. R., Tallman, M. S., Klinge, S. A., McWilliams, N., McKoy, J. M., Kim, B., Lyons, E. A., Trifilio, S. M., Raisch, D. W., Evens, A. M., Kuzel, T. M., Schumock, G. T., Belknap, S. M., Locatelli, F., Rossert, J. and Casadevall, N. (2004). Pure red-cell aplasia and epoetin therapy. N. Engl. J. Med. 351, 1403-1408.
2. Casadevall, N., Dupuy, E., Molho-Sabatier, P., Tobelem, G., Varet, B. and Mayeux, P. (1996). Autoantibodies against erythropoietin in a patient with pure red-cell aplasia. N. Engl. J. Med. 334, 630-633.
3. Casadevall, N., Nataf, J., Viron, B., Kolta, A., Kiladjian, J. J., Martin-Dupont, P., Michaud, P., Papo, T., Ugo, V., Teyssandier, I., Varet, B. and Mayeux, P. (2002). Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N. Engl. J. Med. 346, 469-475.
4. Erslev, A. J. and Besarab, A. (1997). Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure. Kidney Int. 51, 622-630.
5. Gershon, S. K., Luksenburg, H., Cote, T. R. and Braun, M. M. (2002). Pure red-cell aplasia and recombinant erythropoietin. N. Engl. J. Med. 346, 1584-1586; author reply 1584-1586.
6. Gross, J., Moller, R., Bischoff, S., Canaan-Kuhl, S., Fromme, M. and Henke, W. (2008). Detection and characterization of antibodies against recombinant human erythropoietin by RIPA, ELISA and neutralization assay in patients with renal anemia. J. Immunol. Methods 336, 152-158.
7. Gross, J., Moller, R., Henke, W. and Hoesel, W. (2006). Detection of anti-EPO antibodies in human sera by a bridging ELISA is much more sensitive when coating biotinylated rhEPO to streptavidin rather than using direct coating of rhEPO. J. Immunol. Methods 313, 176-182.
8. Hennig, C., Rink, L., Fagin, U., Jabs, W. J. and Kirchner, H. (2000). The influence of naturally occurring heterophilic anti-immunoglobulin antibodies on direct measurement of serum proteins using sandwich ELISAs. J. Immunol. Methods 235, 71-80.
9. Hoesel, W., Gross, J., Moller, R., Kanne, B., Wessner, A., Muller, G., Muller, A., Gromnica-Ihle, E., Fromme, M., Bischoff, S. and Haselbeck, A. (2004). Development and evaluation of a new ELISA for the detection and quantification of antierythropoietin antibodies in human sera. J. Immunol. Methods 294, 101-110.
10. Kientsch-Engel, R., Hallermayer, K. and Dessauer, A. (1989). Methods for measuring erythropoietin and erythropoietin antibodies using ELISA technique. Contrib. Nephrol. 76, 100-105.
11. McKoy, J. M., Stonecash, R. E., Cournoyer, D., Rossert, J., Nissenson, A. R., Raisch, D. W., Casadevall, N. and Bennett, C. L. (2008). Epoetin-associated pure red cell aplasia: past, present, and future considerations. Transfusion (Paris) 48, 1754-1762.
12. Swanson, S. J. (2003). New technologies for the detection of antibodies to therapeutic proteins. Dev. Biol. (Basel) 112, 127-133.
13. Swanson, S. J., Ferbas, J., Mayeux, P. and Casadevall, N. (2004). Evaluation of methods to detect and characterize antibodies against recombinant human erythropoietin. Nephron Clin. Pract. 96, c88-95.
14. Tacey, R., Greway, A., Smiell, J., Power, D., Kromminga, A., Daha, M., Casadevall, N. and Kelley, M. (2003). The detection of anti-erythropoietin antibodies in human serum and plasma. Part I. Validation of the protocol for a radioimmunoprecipitation assay. J. Immunol. Methods 283, 317-329.
15. Thorpe, R. and Swanson, S. J. (2005a). Assays for detecting and diagnosing antibody-mediated pure red cell aplasia (PRCA): an assessment of available procedures. Nephrol. Dial. Transplant. 20(Suppl 4), iv16 22.
16. Thorpe, R. and Swanson, S. J. (2005b). Current methods for detecting antibodies against erythropoietin and other recombinant proteins. Clin. Diagn. Lab. Immunol. 12, 28-39.
17. Tolman, C., Duja, S., Richardson, D., Rashid, R., McVerry, A., Mooney, A., Baker, R. and Will, E. (2004). Four cases of pure red cell aplasia secondary to epoetin beta, with strong temporal relationships. Nephrol. Dial. Transplant. 19, 2133-2136.
18. Urra, J. M., de la Torre, M., Alcazar, R. and Peces, R. (1997). Rapid method for detection of anti recombinant human erythropoietin antibodies as a new form of erythropoietin resistance. Clin. Chem. 43, 848-849.